Q3 sales were SEK 36m (-3% vs. FactSet cons, -8% vs. SEB). At CER, this corresponds to a y/y decline of -20% (SEB at -13%). On a sequential basis, sales were -8% from Q2 at CER. We expected a flat q/q sales development in Q3. EBIT was SEK -7m (cons SEK -11m, SEB SEK -11m) with lower opex. We see up to mid-single-digit cuts to FY 2026E consensus (FactSet) sales.
LÄS MER
